Lysophosphatidic acid (LPA) is an extracellular signaling mediator with a broad range of cellular responses. Three G-protein-coupled receptors (Edg-2, -4, and -7) have been identified as receptors for LPA. In this study, the ectophosphatase lipid phosphate phosphatase 1 (LPP1) has been shown to down-regulate LPAmediated mitogenesis. Furthermore, using degradationresistant phosphonate analogs of LPA and stereoselective agonists of the Edg receptors we have demonstrated that the mitogenic and platelet aggregation responses to LPA are independent of Edg-2, -4, and -7. Specifically, we found that LPA degradation is insufficient to account for the decrease in LPA potency in mitogenic assays, and the stereoselectivity observed at the Edg receptors is not reflected in mitogenesis. Additionally, RH7777 cells, which are devoid of Edg-2, -4, and -7 receptor mRNA, have a mitogenic response to LPA and LPA analogs. Finally, we have determined that the ligand selectivity of the platelet aggregation response is consistent with that of mitogenesis, but not with Edg-2, -4, and -7.The structurally simple phospholipid lysophosphatidic acid (LPA, 1 1-acyl, 2-hydroxy-sn-glycerol-3-phosphate) has been shown in the past decades to mediate an array of biological responses that is anything but simple. LPA has been shown to signal such vital cellular events as mitogenesis (1), platelet aggregation (2), tumor cell invasion (3), and escape from apoptosis (4). LPA is present in serum at low (1-20 M) micromolar concentrations (5) and is produced and released by stimulated platelets (6). The autocrine activation of platelet aggregation, coupled with LPA's mitogenic effects on smooth muscle cells (7) and fibroblasts (8), suggests a functional role for LPA as a wound-healing hormone (see review (9)). Furthermore, LPA accumulates to high concentrations in ovarian cancer ascitic fluid and is mitogenic to ovarian cancer cells, implicating LPA as a marker and mediator of ovarian cancer progression (10).In Recently, specific G-protein-coupled receptors for LPA have been identified within a cluster of eight related receptors termed the Edg (Endothelial differentiation gene) cluster. To date, eight members of the Edg cluster have been described. Edg-2 (15, 19), -4 (20), and -7 (21, 22) have been shown to be LPA receptors and Edg-1 (23, 24), -3, -5 (25), -6 (26, 27), and -8 (28) are receptors for the structurally related phospholipid sphingosine 1-phosphate. The LPA receptors differ with respect to distribution and G-protein coupling. Edg-2 is widely expressed, with highest mRNA levels appearing in brain (20), reflecting expression in Schwann cells and oligodendrocytes (29,30). Edg-4 is most highly expressed in testis and leukocytes (20), whereas Edg-7 is very highly expressed in kidney and prostate (21,22). When stably transfected into the LPA-unresponsive cell line RH7777 (Rat Hepatoma), Edg-2 mediates inhibition of cAMP accumulation, whereas Edg-4 and Edg-7 mediate calcium mobilization (22). Because only the inhibition of cAMP accumulation is pertus...